Home Stock Market News

Stock Market News

Latest

Bellicum Pharmaceuticals: Here’s What Just Happened And Why it Matters

ME Staff - April 12, 2018

Here’s What’s Moving Conatus And Paratek

Here’s Why Rigel Pharmaceuticals And Bio-Path Holdings Are Moving This Week

Edge Therapeutics And Apricus Biosciences Are Moving: Here’s Why

Here’s Why Alder BioPharmaceuticals And Prothena Corporation Are Moving Today

With Shutdown Looming, What If Congress Can’t—Rather Than Won’t—Borrow More Money?

Matt Winkler - January 18, 2018

Three Factors That Suggest A Market Top May Be Close

Bill Feingold - January 16, 2018

What’s Next For Lipocine After A Disappointing Panel Review?

ME Contributor - January 11, 2018

Here’s What Just Happened With Revance Therapeutics Inc (NASDAQ: RVNC) and...

ME Contributor - January 9, 2018

Celgene Corporation (NASDAQ:CELG) Kicks Off J.P. Morgan With A Bang

ME Contributor - January 8, 2018

A Deep Dive Into The Roche Holdings AG Basel ADR Common...

ME Contributor - January 5, 2018

Here’s How Pfizer Inc. (NYSE: PFE) Has Had A Mixed Start...

ME Contributor - January 4, 2018

Two Companies To Watch This Week: Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) And...

ME Contributor - January 3, 2018

Here’s What’s Moving Galena Biopharma, Inc. (NASDAQ:GALE) and Progenics Pharmaceuticals, Inc....

ME Contributor - January 2, 2018

Biotech Movers: Agile Therapeutics, Inc., (NASDAQ:AGRX) and GW Pharmaceuticals plc (NASDAQ:GWPH)

ME Contributor - December 29, 2017

1 234...123 Page 3 of 123

EDITOR PICKS

Market Exclusive Daily Roundup, What You Need To Know April 18

April 18, 2018

Here’s What Happened Last Week In Biotech

April 17, 2018

ArQule, Inc. Is Moving On ASCO Release, Here’s Why.

April 16, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.